Sources

The evidence and statistics is drawn from peer-reviewed research papers published in high-quality journals.

Home page 

  1. Gaul C, Diener HC, Danesch U, Migravent® Study Group. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. The journal of headache and pain. 2015 Dec;16(1):32.

Our approach 

  1. Cen J, Wang Q, Cheng L, Gao Q, Wang H, Sun F. Global, regional, and national burden and trends of migraine among women of childbearing age from 1990 to 2021: insights from the Global Burden of Disease Study 2021. The journal of headache and pain. 2024 Jun 7;25(1):96.
  2. Al-Hassany L, Haas J, Piccininni M, Kurth T, Maassen Van Den Brink A, Rohmann JL. Giving researchers a headache–sex and gender differences in migraine. Frontiers in neurology. 2020 Oct 22;11:549038.
  3. Seo JG. Menstrual migraine: a review of current research and clinical challenges. Headache and Pain Research. 2024 Apr 22;25(1):16-23.
  4. Kvisvik EV, Stovner LJ, Helde G, Bovim G, Linde M. Headache and migraine during pregnancy and puerperium: the MIGRA-study. The journal of headache and pain. 2011 Aug;12(4):443-51.

What we offer

  1. Gaul C, Diener HC, Danesch U, Migravent® Study Group. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. The journal of headache and pain. 2015 Dec;16(1):32.
  2. Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache: The Journal of Head and Face Pain. 1991 May;31(5):298-301.
  3. Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996 Jun;16(4):257-63.
  4. Boehnke C, Reuter U, Flach U, Schuh‐Hofer S, Einhäupl KM, Arnold G. High‐dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. European Journal of Neurology. 2004 Jul;11(7):475-7.
  5. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high‐dose riboflavin in migraine prophylaxis A randomized controlled trial. Neurology. 1998 Feb;50(2):466-70.